[Use of polysaccharide prodigiozan in the complex therapy of chronic and residual brucellosis].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use; D002006:Brucellosis / Q000188:drug therapy* / Q000201:enzymology / Q000276:immunology; D002908:Chronic Disease; D004342:Drug Hypersensitivity / Q000276:immunology; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D009113:Muramidase / Q000097:blood; D009827:Oleandomycin / Q000627:therapeutic use; D010587:Phagocytosis / Q000187:drug effects; D026741:Physical Therapy Modalities; D010860:Pigments, Biological / Q000627:therapeutic use*; D011353:Prodigiosin / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D012706:Serratia marcescens; D013268:Stimulation, Chemical; D013752:Tetracycline / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010860:Pigments, Biological; D011758:Pyrroles; D014815:Vitamins; D009113:Muramidase; D013752:Tetracycline; D011353:Prodigiosin; D009827:Oleandomycin; D001205:Ascorbic Acid
Primenenie lipopolisakharida prodigiozana v kompleksnom echenii khronicheskogo i rezidual'nogo brutselleza.